Central Trust Company’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Central Trust Company’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300	Closed	-$6K	–	1364
2021 Q3	$6K	Hold	300	–	–	﹤0.01%	1110
2021 Q2	$11K	Buy	+300	New	+$9.2K	﹤0.01%	1013

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Central Trust Company's DRNA Position: Q4 2021 in Review

Central Trust Company sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 300 shares — an estimated $6K sold.

Central Trust Company first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $11K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Central Trust Company reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Central Trust Company sold 300 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $6K.
Central Trust Company first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Central Trust Company's Dicerna Pharmaceuticals, Inc. position peaked at $11K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Central Trust Company's 13F filing for Q4 2021, filed 8 Feb 2022.